Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

March 26, 2021 Auto Bot Children, Clinical Trials, Covid-19 Vaccine, Initiates, Trial 0

Shots:

  • The companies have started testing BNT162b2 in children aged 6-11yrs. with initial results anticipated in H2’21. The companies are planning to expand the vaccination to that age range by early 2022
  • The companies plan to initiate the safety of BNT162b2 (10/20/30µg) vs PBO in P-I/II trial in 144-participant
  • Pfizer and BioNTech later plan to expand the trial to 4,500-participant to evaluate the safety, tolerability and immune response of the vaccine in kids. Meanwhile, Pfizer has been testing the vaccine in children from aged 12-15yrs. and anticipating results in coming weeks

Click here ­to­ read full press release/ article | Ref: Reuters | Image: WebMD

The post Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12 first appeared on PharmaShots.